首页> 外文期刊>STEM CELLS >Brief Report - Human Embryonic Stem Cell-Derived Mesenchymal Progenitors Possess Strong Immunosuppressive Effects Toward Natural Killer Cells as Well as T Lymphocytes§
【24h】

Brief Report - Human Embryonic Stem Cell-Derived Mesenchymal Progenitors Possess Strong Immunosuppressive Effects Toward Natural Killer Cells as Well as T Lymphocytes§

机译:简要报告-人类胚胎干细胞衍生的间充质祖细胞对自然杀伤细胞以及T淋巴细胞具有强大的免疫抑制作用 §

获取原文
获取原文并翻译 | 示例
           

摘要

The derivation of mesenchymal progenitors from human embryonic stem cells (hESCs) has recently been reported. We studied the immune characteristics of these hESC-derived mesenchymal progenitors (EMPs) and their interactions with T lymphocytes and natural killer cells (NKs), two populations of lymphocytes with important roles in transplantation immunology. EMPs express a number of bone marrow mesenchymal stromal cell (BMMSC) markers, as well as the hESC marker SSEA-4. Immunologically, EMPs do not express HLA-DR or costimulatory molecules. On the other hand, HLA-G, a nonclassic MHC I protein involved in mediating maternal-fetal tolerance, can be found on the surface of EMPs, and its expression is increased after interferon- stimulation. EMPs can suppress CD4+ or CD8+ lymphocyte proliferation, similar to BMMSCs. However, EMPs are more resistant to NK-mediated lysis than BMMSCs and can suppress the cytotoxic effects of activated NKs, as well as downregulating the NK-activating receptors NKp30 and NKp46. With their broad immunosuppressive properties, EMPs may represent a new potential cell source for therapeutic use. STEM CELLS 2009;27:451-456
机译:最近已经报道了从人胚胎干细胞(hESCs)衍生间充质祖细胞。我们研究了这些hESC来源的间充质祖细胞(EMP)的免疫特性,以及它们与T淋巴细胞和自然杀伤细胞(NK)的相互作用,T淋巴细胞和自然杀伤细胞是在移植免疫学中具有重要作用的两个淋巴细胞群。 EMPs表达许多骨髓间充质基质细胞(BMMSC)标记以及hESC标记SSEA-4。在免疫学上,EMP不表达HLA-DR或共刺激分子。另一方面,可以在EMPs的表面上发现HLA-G,一种非典型的MHC I蛋白,介导母胎耐受性,在干扰素刺激后其表达增加。 EMPs可以抑制CD4 +或CD8 +淋巴细胞的增殖,类似于BMMSC。但是,EMP比BMMSC对NK介导的裂解更具抵抗力,并且可以抑制活化的NK的细胞毒性作用,并下调NK活化受体NKp30和NKp46。 EMP具有广泛的免疫抑制特性,可能代表了治疗用途的新的潜在细胞来源。干细胞2009; 27:451-456

著录项

  • 来源
    《STEM CELLS》 |2009年第2期|451-456|共6页
  • 作者单位

    Regenerative Medicine Research Group, Institute of Cellular and System Medicine, National Health Research Institutes, Zhunan, Taiwan|Department of Obstetrics/Gynecology, Cathay General Hospital Sijhih, Taipei, Taiwan;

    Regenerative Medicine Research Group, Institute of Cellular and System Medicine, National Health Research Institutes, Zhunan, Taiwan;

    National Institute of Cancer Research, National Health Research Institutes, Zhunan, Taiwan;

    Regenerative Medicine Research Group, Institute of Cellular and System Medicine, National Health Research Institutes, Zhunan, Taiwan|Department of Laboratory Medicine, National Taiwan University Hospital and College of Medicine, National Taiwan University, Taipei, Taiwan|Department of Forensic Medicine, National Taiwan University Hospital and College of Medicine, National Taiwan University, Taipei, Taiwan;

    Regenerative Medicine Research Group, Institute of Cellular and System Medicine, National Health Research Institutes, Zhunan, Taiwan|Department of Primary Care Medicine, National Taiwan University Hospital and College of Medicine, National Taiwan University, Taipei, Taiwan;

    Central Laboratory, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan;

    Department of Primary Care Medicine, National Taiwan University Hospital and College of Medicine, National Taiwan University, Taipei, Taiwan|Department of Obstetrics/Gynecology, National Taiwan University Hospital and College of Medicine, National Taiwan University, Taipei, Taiwan;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号